Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

The Dorsal Column Lesion Model of Spinal Cord Injury and Its Use in Deciphering the Neuron-Intrinsic Injury Response.

Attwell CL, van Zwieten M, Verhaagen J, Mason MRJ.

Dev Neurobiol. 2018 Oct;78(10):926-951. doi: 10.1002/dneu.22601. Epub 2018 May 11. Review.

2.

Patients׳ perspectives on how treatment can impede their recovery from depression.

van Grieken RA, Beune EJ, Kirkenier AC, Koeter MW, van Zwieten MC, Schene AH.

J Affect Disord. 2014;167:153-9. doi: 10.1016/j.jad.2014.05.065. Epub 2014 Jun 6.

PMID:
24972363
3.

Nurses' experiences and perspectives on medication safety practices: an explorative qualitative study.

Smeulers M, Onderwater AT, van Zwieten MC, Vermeulen H.

J Nurs Manag. 2014 Apr;22(3):276-85. doi: 10.1111/jonm.12225. Epub 2014 Mar 18.

PMID:
24635029
4.

A qualitative participatory study to identify experiences of coronary heart disease patients to support the development of online self-management services.

Vosbergen S, Janzen J, Stappers PJ, van Zwieten MC, Lacroix J, Idema K, van den Broek I, Kemps HM, Kraaijenhagen RA, Peek N.

Int J Med Inform. 2013 Dec;82(12):1183-94. doi: 10.1016/j.ijmedinf.2013.09.001. Epub 2013 Sep 17.

PMID:
24113277
5.

The influence of medical testing on patients' health: an overview from the gynecologists' perspective.

Vis JY, van Zwieten MC, Bossuyt PM, Moons KG, Dijkgraaf MG, McCaffery KJ, Mol BW, Opmeer BC.

BMC Med Inform Decis Mak. 2013 Oct 10;13:117. doi: 10.1186/1472-6947-13-117.

6.

Patients' and professionals' barriers and facilitators to external cephalic version for breech presentation at term, a qualitative analysis in the Netherlands.

Rosman AN, Vlemmix F, Fleuren MA, Rijnders ME, Beuckens A, Opmeer BC, Mol BW, van Zwieten MC, Kok M.

Midwifery. 2014 Mar;30(3):324-30. doi: 10.1016/j.midw.2013.03.013. Epub 2013 May 9.

PMID:
23664312
7.

Fabry patients' experiences with the timing of diagnosis relevant for the discussion on newborn screening.

Bouwman MG, de Ru MH, Linthorst GE, Hollak CE, Wijburg FA, van Zwieten MC.

Mol Genet Metab. 2013 Jun;109(2):201-7. doi: 10.1016/j.ymgme.2013.03.008. Epub 2013 Mar 21.

PMID:
23566439
8.

Work participation and arthritis: a systematic overview of challenges, adaptations and opportunities for interventions.

Hoving JL, van Zwieten MC, van der Meer M, Sluiter JK, Frings-Dresen MH.

Rheumatology (Oxford). 2013 Jul;52(7):1254-64. doi: 10.1093/rheumatology/ket111. Epub 2013 Mar 7. Review.

PMID:
23472042
9.

Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening.

de Ru MH, Bouwman MG, Wijburg FA, van Zwieten MC.

Mol Genet Metab. 2012 Nov;107(3):501-7. doi: 10.1016/j.ymgme.2012.08.008. Epub 2012 Aug 16.

PMID:
22926196
10.

Research monitoring by US medical institutions to protect human subjects: compliance or quality improvement?

de Jong JP, van Zwieten MC, Willems DL.

J Med Ethics. 2013 Apr;39(4):236-41. doi: 10.1136/medethics-2011-100434. Epub 2012 Aug 18.

PMID:
22902386
11.

Ethical review from the inside: repertoires of evaluation in Research Ethics Committee meetings.

de Jong JP, van Zwieten MC, Willems DL.

Sociol Health Illn. 2012 Sep;34(7):1039-52. doi: 10.1111/j.1467-9566.2012.01458.x. Epub 2012 Feb 14.

12.

The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer.

Engelen V, van Zwieten M, Koopman H, Detmar S, Caron H, Brons P, Egeler M, Kaspers GJ, Grootenhuis M.

Pediatr Blood Cancer. 2012 Jul 15;59(1):161-6. doi: 10.1002/pbc.24089. Epub 2012 Jan 23.

PMID:
22271750
13.

Counselling on disclosure of gamete donation to donor offspring:a search for facts.

Visser M, Kop PA, van Wely M, van der Veen F, Gerrits GJ, van Zwieten MC.

Facts Views Vis Obgyn. 2012;4(3):159-72. Review.

14.

The prevalence of chronic psychological complaints and emotional exhaustion among overweight and obese workers.

Proper KI, Koppes LL, van Zwieten MH, Bemelmans WJ.

Int Arch Occup Environ Health. 2012 Jul;85(5):537-45. doi: 10.1007/s00420-011-0703-y. Epub 2011 Sep 27.

PMID:
21947369
15.

Patients' and professionals' barriers and facilitators of tailored expectant management in subfertile couples with a good prognosis of a natural conception.

van den Boogaard NM, van den Boogaard E, Bokslag A, van Zwieten MC, Hompes PG, Bhattacharya S, Nelen W, van der Veen F, Mol BW.

Hum Reprod. 2011 Aug;26(8):2122-8. doi: 10.1093/humrep/der175. Epub 2011 Jun 10.

PMID:
21665873
16.

Disentangling cancer patients' trust in their oncologist: a qualitative study.

Hillen MA, Onderwater AT, van Zwieten MC, de Haes HC, Smets EM.

Psychooncology. 2012 Apr;21(4):392-9. doi: 10.1002/pon.1910. Epub 2011 Jan 30.

PMID:
21280138
17.

Patients' view on screening for depression in general practice.

Wittkampf KA, van Zwieten M, Smits FT, Schene AH, Huyser J, van Weert HC.

Fam Pract. 2008 Dec;25(6):438-44. doi: 10.1093/fampra/cmn057. Epub 2008 Oct 3.

PMID:
18836095
18.

Psychiatric and psychological factors in patient decision making concerning antidepressant use.

Dijkstra A, Jaspers M, van Zwieten M.

J Consult Clin Psychol. 2008 Feb;76(1):149-57. doi: 10.1037/0022-006X.76.1.149.

PMID:
18229992
19.

Comparing genetic counseling with non-genetic health care interactions: two of a kind?

Smets E, van Zwieten M, Michie S.

Patient Educ Couns. 2007 Nov;68(3):225-34. Epub 2007 Jul 2. Review.

PMID:
17604936
20.

Randomized, controlled trials in the emergency setting: a matter of physician-patient relationships, responsibility, and trust.

Bos AP, van Zwieten MC.

Crit Care Med. 2007 Mar;35(3):979-80. No abstract available.

PMID:
17421105
21.

[Rapid prenatal diagnosis of chromosomal abnormalities; limitations and possibilities].

van Zwieten MC, Leschot NJ, Willems DL.

Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2454; author reply 2454. Dutch. No abstract available.

PMID:
17131706
22.

Communication with patients during the prenatal testing procedure: an explorative qualitative study.

van Zwieten M, Willems D, Knegt L, Leschot N.

Patient Educ Couns. 2006 Oct;63(1-2):161-8. Epub 2006 Jan 6.

PMID:
16406463
23.

How unexpected are unexpected findings in prenatal cytogenetic diagnosis? A literature review.

van Zwieten MC, Willems DL, Litjens LL, Schuring-Blom HG, Leschot N.

Eur J Obstet Gynecol Reprod Biol. 2005 May 1;120(1):15-21. Review.

PMID:
15866080
24.

A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.

DeFeo-Jones D, Brady SF, Feng DM, Wong BK, Bolyar T, Haskell K, Kiefer DM, Leander K, McAvoy E, Lumma P, Pawluczyk JM, Wai J, Motzel SL, Keenan K, Van Zwieten M, Lin JH, Garsky VM, Freidinger R, Oliff A, Jones RE.

Mol Cancer Ther. 2002 May;1(7):451-9.

25.

Impairment of male fertility induced by muscarinic receptor antagonists in rats.

Ban Y, Sato T, Nakatsuka T, Kemi M, Samura K, Matsumoto H, Cukierski MA, van Zwieten MJ.

Reprod Toxicol. 2002 Nov-Dec;16(6):757-65.

PMID:
12401503
26.

Muscarinic receptor antagonist-induced lenticular opacity in rats.

Durand G, Hubert MF, Kuno H, Cook WO, Boussiquet-Leroux C, Owen R, Fujimaki Y, Kemi M, Virat M, van Zwieten MJ.

Toxicol Sci. 2002 Mar;66(1):166-72.

PMID:
11861984
27.

A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo.

DeFeo-Jones D, Garsky VM, Wong BK, Feng DM, Bolyar T, Haskell K, Kiefer DM, Leander K, McAvoy E, Lumma P, Wai J, Senderak ET, Motzel SL, Keenan K, Van Zwieten M, Lin JH, Freidinger R, Huff J, Oliff A, Jones RE.

Nat Med. 2000 Nov;6(11):1248-52.

PMID:
11062536
28.

Morphological changes in the kidney of dogs chronically exposed to exogenous growth hormone.

Molon-Noblot S, Laroque P, Prahalada S, Stabinski LG, Peter CP, Duprat P, van Zwieten MJ.

Toxicol Pathol. 2000 Jul-Aug;28(4):510-7.

PMID:
10930036
29.

The relative protective effects of moderate dietary restriction versus dietary modification on spontaneous cardiomyopathy in male Sprague-Dawley rats.

Kemi M, Keenan KP, McCoy C, Hoe CM, Soper KA, Ballam GC, van Zwieten MJ.

Toxicol Pathol. 2000 Mar-Apr;28(2):285-96.

PMID:
10805146
30.

The carcinogenic risk of high dose total body irradiation in non-human primates.

Broerse JJ, Bartstra RW, van Bekkum DW, van der Hage MH, Zurcher C, van Zwieten MJ, Hollander CF.

Radiother Oncol. 2000 Mar;54(3):247-53.

PMID:
10738083
31.

Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.

Prahalada S, Block G, Handt L, DeBurlet G, Cahill M, Hoe CM, van Zwieten MJ.

Horm Metab Res. 1999 Feb-Mar;31(2-3):133-7.

PMID:
10226793
32.

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.

Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ.

Prostate. 1998 May 15;35(3):157-64.

PMID:
9582084
33.

Effect of chronic growth hormone administration on skeletal muscle in dogs.

Molon-Noblot S, Laroque P, Prahalada S, Stabinski LG, Hoe CM, Peter CP, Duprat P, van Zwieten MJ.

Toxicol Pathol. 1998 Mar-Apr;26(2):207-12.

PMID:
9547857
34.

Morphological changes in the pituitary gland of dogs chronically exposed to exogenous growth hormone.

Laroque P, Molon-Noblot S, Prahalada S, Stabinski LG, Hoe CM, Peter CP, Duprat P, van Zwieten MJ.

Toxicol Pathol. 1998 Mar-Apr;26(2):201-6.

PMID:
9547856
35.

Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs.

Prahalada S, Stabinski LG, Chen HY, Morrissey RE, De Burlet G, Holder D, Patrick DH, Peter CP, van Zwieten MJ.

Toxicol Pathol. 1998 Mar-Apr;26(2):185-200.

PMID:
9547855
36.

Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors.

Laroque PA, Prahalada S, Molon-Noblot S, Cohen SM, Soper K, Duprat P, Peter CP, van Zwieten MJ.

Prostate. 1995 Sep;27(3):121-8.

PMID:
7567690
37.

Induction of minisatellite DNA rearrangements by genotoxic carcinogens in mouse liver tumors.

Ledwith BJ, Joslyn DJ, Troilo P, Leander KR, Clair JH, Soper KA, Manam S, Prahalada S, van Zwieten MJ, Nichols WW.

Carcinogenesis. 1995 May;16(5):1167-72.

PMID:
7767981
38.

Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.

Manam S, Shinder GA, Joslyn DJ, Kraynak AR, Hammermeister CL, Leander KR, Ledwith BJ, Prahalada S, van Zwieten MJ, Nichols WW.

Carcinogenesis. 1995 May;16(5):1113-9.

PMID:
7767973
39.

Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.

Prahalada SR, Keenan KP, Hertzog PR, Gordon LR, Peter CP, Soper KA, van Zwieten MJ, Bokelman DL.

Urology. 1994 May;43(5):680-5.

PMID:
7513109
40.

Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.

Prahalada S, Majka JA, Soper KA, Nett TM, Bagdon WJ, Peter CP, Burek JD, MacDonald JS, van Zwieten MJ.

Fundam Appl Toxicol. 1994 Feb;22(2):211-9.

PMID:
8005373
41.

Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate.

Laroque PA, Prahalada S, Gordon LR, Noblot SM, Bagdon WJ, Duprat P, Peter CP, Van Zwieten MJ.

Prostate. 1994;24(2):93-100.

PMID:
8309848
42.

Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists.

Grossman SJ, DeLuca JG, Zamboni RJ, Keenan KP, Patrick DH, Herold EG, van Zwieten MJ, Zacchei AG.

Toxicol Appl Pharmacol. 1992 Oct;116(2):217-24.

PMID:
1412466
43.

Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.

Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Ledwith BJ, van Zwieten MJ, Bradley MO, Nichols WW.

Cancer Res. 1992 Jun 15;52(12):3347-52.

44.

Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.

Goodrow TL, Prahalada SR, Storer RD, Manam SV, Leander KR, Kraynak AR, van Zwieten MJ, Nichols WW, Bradley MO.

Lab Invest. 1992 Apr;66(4):504-11.

PMID:
1583889
45.

Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.

Goodrow TL, Storer RD, Leander KR, Prahalada SR, van Zwieten MJ, Bradley MO.

Mol Carcinog. 1992;5(1):9-15.

PMID:
1543544
46.

Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice.

Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Hammermeister CL, Joslyn DJ, Ledwith BJ, van Zwieten MJ, Bradley MO, et al.

Mol Carcinog. 1992;6(1):68-75.

PMID:
1503645
47.

Monoclonal gammapathies in long-term surviving rhesus monkeys after lethal irradiation and bone marrow transplantation.

Radl J, Liu M, Hoogeveen CM, van den Berg P, Minkman-Brondijk RJ, Broerse JJ, Zurcher C, van Zwieten MJ.

Clin Immunol Immunopathol. 1991 Aug;60(2):305-9.

PMID:
2070572
48.

Radiation carcinogenesis in large animals.

Zurcher C, van Zwieten MJ, Hollander CF, Broerse JJ.

Radiat Environ Biophys. 1991;30(3):243-7. Review. No abstract available.

PMID:
1924715
49.

The daily intravenous administration of acidic fibroblast growth factor induces goiter in rats.

Huber AC, Van Zwieten MJ, DeVito WJ, Braverman LE.

Trans Assoc Am Physicians. 1991;104:273-7. No abstract available.

PMID:
1726966
50.

DNA fingerprinting of 7,12-dimethylbenz[a]anthracene-induced and spontaneous CD-1 mouse liver tumors.

Ledwith BJ, Storer RD, Prahalada S, Manam S, Leander KR, van Zwieten MJ, Nichols WW, Bradley MO.

Cancer Res. 1990 Sep 1;50(17):5245-9.

Supplemental Content

Loading ...
Support Center